AGITATION IN DEMENTIA
Mercury Clinical Research is seeking adult volunteers to participate in a study to evaluate the efficacy, safety, and tolerability of an investigational medication in the treatment of patients with Agitation in associated with Dementia of the Alzheimer’s type.
Be assured that all information is kept strictly confidential per HIPAA regulations, FDA laws, and the American Medical Association ethical guidelines. Compensation may be provided to those that qualify in the study.
This trial is currently enrolling.